Researchers Found Tau Filaments Changed Shape

Scientists at the University of Pennsylvania discovered that tau proteins can adopt new structures after their initial formation.

Updated on Oct. 11, 2026 in Alzheimer’s

Microscopic view of complex, branched protein filaments with cyan highlights against a dark navy background.
University of Pennsylvania researchers identified six new structural shapes in tau protein filaments, potentially offering new targets for neurodegenerative disease therapies. AI Illustration. Upload story photo >

Live Poll

Do you believe current research on tau proteins will lead to effective new dementia treatments?

Researchers discovered that tau filaments can alter their structures after forming, a breakthrough in understanding neurodegenerative conditions. The team identified six new tau filament shapes in patients with vacuolar tauopathy using cryo-electron microscopy.

Why it matters

Understanding how tau filaments modify their structure could offer a path toward reducing the spread of diseases like Alzheimer's. This discovery suggests that tau structures are more dynamic than previously understood, potentially enabling new therapeutic interventions.

Researchers identified two core tau structures in Alzheimer's disease tissue and five variants in vacuolar tauopathy. The addition of ubistatin B led to the observation of six previously unidentified tau filament shapes.

The players

Edward Lee

He is a researcher who identified that VCP gene mutations are the cause of vacuolar tauopathy.

University of Pennsylvania

This is the research institution where the study on tau filament structures was conducted.

The details

The study utilized cryo-electron microscopy to visualize tau filaments and hypothesized that densities surrounding tau cores were ubiquitin molecules. By adding ubistatin B to stabilize these molecules, researchers successfully induced six new filament shapes in samples from patients with vacuolar tauopathy, a condition linked to VCP gene mutations.

Timeline

  1. Edward Lee discovered that VCP gene mutations cause vacuolar tauopathy in 2020.

  2. The study regarding shifting tau filament structures was published in October 2026.

The Big Picture

This discovery marks a departure from the established hypothesis that tau protein structures are static once formed in the brain. It shifts the trajectory of research by demonstrating that tau filaments can undergo structural modifications, opening new possibilities for future drug development.

This research provides a deeper understanding of the physical changes in the brain associated with conditions like vacuolar tauopathy and Alzheimer's disease. While not an immediate treatment, identifying how these proteins change could eventually lead to new therapeutic strategies for managing cognitive decline.

The takeaway

This study reveals that tau filaments are more dynamic than once thought, providing a new target for scientists studying brain health. Future research will focus on whether similar structural changes contribute to the progression of other neurodegenerative disorders.

What happens next

Researchers plan to expand their investigation by testing whether these structural shifts occur in fibrils from other tau-linked diseases.

Further reading

Learn more about the latest research in our Alzheimer’s section.

Live Poll

Do you believe current research on tau proteins will lead to effective new dementia treatments?